Drug Shortage Report for FULPHILA

Last updated on 2023-04-20 History
Report ID 176254
Drug Identification Number 02484153
Brand name FULPHILA
Common or Proper name Pegfilgrastim
Company Name BIOSIMILAR COLLABORATIONS IRELAND LIMITED
Market Status MARKETED
Active Ingredient(s) PEGFILGRASTIM
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size single dose syringe containing 6mg pegfilgrastim in 0.6mL (10mg/mL)
ATC code L03AA
ATC description IMMUNOSTIMULANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-12-07
Actual start date 2022-12-12
Estimated end date 2023-03-14
Actual end date 2023-03-30
Shortage status Resolved
Updated date 2023-04-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13
DUBLIN, --
IRELAND D13R20R
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-04-20 French Compare
v14 2023-04-20 English Compare
v13 2023-02-01 French Compare
v12 2023-02-01 English Compare
v11 2023-01-17 French Compare
v10 2023-01-17 English Compare
v9 2023-01-10 French Compare
v8 2023-01-10 English Compare
v7 2022-12-19 French Compare
v6 2022-12-19 English Compare
v5 2022-12-08 French Compare
v4 2022-12-08 English Compare
v3 2022-12-08 English Compare
v2 2022-11-29 French Compare
v1 2022-11-29 English Compare

Showing 1 to 15 of 15